The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Bender Lewis H since 2008.
The trader's CIK number is 1238705.
At the time of the last reporting, Bender Lewis H was the Chief Executive Offi of Interleukin Genetics Inc. (stock ticker symbol ILI).
Also see all insider trading activities at Interleukin Genetics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | ILI | 63,000 | $23,804 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-11-21 | ILI | Buy | 10,000 | .27 | 2,700 |
| 2008-11-24 | ILI | Buy | 20,000 | .25 | 4,920 |
| 2008-11-20 | ILI | Buy | 11,700 | .33 | 3,896 |
| 2008-11-18 | ILI | Buy | 18,300 | .44 | 8,088 |
| 2008-02-19 | ILI | Buy | 3,000 | 1.40 | 4,200 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bender Lewis H (Chief Executive Offi of Interleukin Genetics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.